Journament

Keyword Connections - inflammatory bowel disease Keywords

Connection Type	Connection
Journals	Nutrients PloS one The Journal of clinical investigation inflammatory bowel diseases Proceedings of the National Academy of Sciences of the United States of America clinical microbiology reviews family medicine contemporary clinical trials communications Journal of gastroenterology and hepatology journal of nanobiotechnology physiologia plantarum Obstetrics and gynecology Journal of clinical immunology international dental journal The Journal of the Association of Physicians of India Gut journal of biomechanical engineering digestion international journal of radiation oncology, biology, physics journal of gastrointestinal surgery : official journal of the society for surgery of the alimentary tract the journal of urology annals of gastroenterology Qualitative Health Research ebiomedicine journal of medicinal food frontline gastroenterology revista espanola de patologia : publicacion oficial de la sociedad espanola de anatomia patologica y de la sociedad espanola de citologia journal of gastroenterology pharmacology & therapeutics journal of crohn's & colitis visceral medicine Journal of medical ultrasonics (2001) arab journal of gastroenterology : the official publication of the pan-arab association of gastroenterology oral health and dental management therapeutic advances in gastroenterology
Research Groups	No Research Group Connected
Bibliographies	[1] [Hodgkin's lymphoma associated with inflammatory bowel disease treated with thiopurines. A case report and review of the literature]. [2] Shared decision making in IBD: A novel approach to trial consent and timing. [3] Inflammatory and immunometabolic consequences of gut dysfunction in HIV: Parallels with IBD and implications for reservoir persistence and non-AIDS comorbidities. [4] Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT. [5] The epidemiology of inflammatory bowel disease: East meets West. [6] Training Residents in Maternal Depression Care to Improve Child Health: A CERA Study. [7] Measuring Three-dimensional Knee Kinematics Using a Femoral Clamp: Accuracy, Repeatability and Reproducibility in Gait. [8] Successful development of methodology for detection of hapten-specific contact hypersensitivity (CHS) memory in swine. [9] The cost-effectiveness of controlling cervical cancer using a new 9-valent human papillomavirus vaccine among school-aged girls in Australia. [10] How does the method change what we measure? Comparing virtual reality and text-based surveys for the assessment of moral decisions in traffic dilemmas. [11] Inter-individual genomic heterogeneity within European population isolates. [12] 2019 Guts UK/Dr Falk awards are open for applications. [13] High-resolution melt analysis enables simple genotyping of complicated polymorphisms of codon 18 rendering the NUDT15 diplotype. [14] Comparative metabolomics analysis reveals different metabolic responses to drought in tolerant and susceptible poplar species. [15] Decreasing Colectomy Rates in Ulcerative Colitis in the Past Decade: Improved Disease Control? [16] Re: Characterisation of Human Urethral Rupture Thresholds for Urinary Catheter Inflation Related Injuries. [17] Generics and Biosimilars; A Step Towards Sustainable and Low Cost Health Care. [18] Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target. [19] Enhanced E. coli LF82 translocation through follicle-associated epithelium in Crohn's disease is dependent on long polar fimbriae and CEACAM6-expression, and increases paracellular permeability. [20] Pathobionts Associated with Inflammatory Bowel Disease. [21] The Gut Microbiome in Inflammatory Bowel Diseases: Diagnostic and Therapeutic Implications. [22] When Family Don't Acknowledge: A Hermeneutic Study of the Experience of Kinship Stigma in Community-Dwelling People With Inflammatory Bowel Disease. [23] Small-molecule inhibitors directly target CARD9 and mimic its protective variant in inflammatory bowel disease. [24] Increased risks of dental caries and periodontal disease in Chinese patients with inflammatory bowel disease. [25] Semen Quality and Sperm DNA Integrity in Patients With Severe Active Inflammatory Bowel Disease and Effects of Tumour Necrosis Factor-alpha Inhibitors. [26] Leter to the Editor. [27] Sperm DNA Integrity is Unaffected by Thiopurine Treatment in Men With Inflammatory Bowel Disease. [28] Orally administered gold nanoparticles protect against colitis by attenuating Toll-like receptor 4- and reactive oxygen/nitrogen species-mediated inflammatory responses but could induce gut dysbiosis in mice. [29] Latent tuberculosis screening tests and active tuberculosis infection rates in Turkish inflammatory bowel disease patients under anti-tumor necrosis factor therapy. [30] Prevalence and characterıstıcs of supernumerary teeth in a child population from Central Anatolıa - Turkey. [31] A Case-Based Approach to New Directions in Dietary Therapy of Crohn's Disease: Food for Thought. [32] Involvement of digestive system in COVID-19: manifestations, pathology, management and challenges. [33] Evaluating the effect of infliximab on the healing of left colonic anastomosis in the presence of intra-abdominal sepsis. [34] Effectiveness and Nephrotoxicity of Long-Term Tacrolimus Administration in Patients with Ulcerative Colitis [35] markery zapalenia, aktywacja płytek krwi i zaburzenia krzepnięcia w chorobach zapalnych jelit [36] do probiotic preparations for humans really have efficacy? [37] multidrug resistance 1 gene polymorphisms may determine crohn's disease behavior in patients from rio de janeiro [38] vedolizumab in patients with inflammatory bowel diseases of in real clinical practice [39] nlrx1 modulates immunometabolic mechanisms controlling the host–gut microbiota interactions during inflammatory bowel disease [40] intestinal epithelium in inflammatory bowel disease [41] rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach [42] inflammatory bowel disease-related arthritis – clinical evaluation and possible role of cytokines [43] Nutritional Interventions Using Functional Foods and Nutraceuticals to Improve Inflammatory Bowel Disease. [44] are novel allergen or hydrolysed diets an effective means of reducing the gastro-intestinal signs in dogs with inflammatory bowel disease when compared to oral prednisolone? [45] qualidade de vida de pacientes portadores de doença inflamatória intestinal calidad de vida de pacientes portadores de enfermedad inflamatoria intestinal quality of life of patients with inflammatory bowel disease [46] combined treatment with hyaluronic acid and mesalamine protects rats from inflammatory bowel disease induced by intracolonic administration of trinitrobenzenesulfonic acid [47] drug therapy: dose-response relationship of oral mesalazine in inflammatory bowel disease [48] the impact of glutathione s–transferase genotype and phenotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases [49] death receptor 3 signaling controls the balance between regulatory and effector lymphocytes in samp1/yitfc mice with crohn’s disease-like ileitis [50] editorial: sedentary behavior in human health and disease [51] body composition as an indicator of the nutritional status in children with newly diagnosed ulcerative colitis and crohn’s disease – a prospective study [52] induction of an antigen specific gut inflammatory reaction in mice and rats: a model for human inflammatory bowel disease [53] evaluation of anti-inflammatory effect of salvadora persica in ibd-induced rat [54] ¿cuándo es demasiado pronto y cuándo demasiado tarde para la cirugía en la enfermedad de crohn? when is it too early or too late for surgery in crohn's disease? [55] endoscopic optical enhancement technologies in ibd [56] azathioprine in inflammatory bowel disease, a safe alternative? [57] drugs as causative agents and therapeutic agents in inflammatory bowel disease [58] association between organochlorine pesticide levels in breast milk and their effects on female reproduction in a taiwanese population [59] imaging of mucosal inflammation: current technological developments, clinical implications, and future perspectives [60] regulation of nuclear factor-κb in intestinal epithelial cells in a cell model of inflammation [61] point of care testing of fecal calprotectin as a substitute for routine laboratory analysis [62] pancreatic involvement in pediatric inflammatory bowel disease [63] fecal calprotectin level as diagnostic marker for intestinal inflammation in inflammatory bowel disease patients [64] anti-inflammatory effects of herbal preparations stw5 and stw5-ii in cytokine-challenged normal human colon cells. [65] an integrated outlook on the metagenome and metabolome of intestinal diseases [66] T1359 Anal Sphincter Responses to Different Patterns of Rectal Distension in Inflammatory Bowel Disease: A Role in Fecal Incontinence [67] T1358 Anorectal Dysfunction Phenotypes in Inflammatory Bowel Disease: Manometric, Sensorimotor and Endosonographic Components [68] Serum IGF-1 and IGFBP3 in inflammatory bowel disease [69] Plasminogen, a2-antiplasmin, D-dimer, FX III and plasminogen activator inhibitor in inflammatory bowel disease [70] NADPH Oxidase Limits Innate Immune Responses in the Lungs in Mice [71] Diagnosis of ulcerative colitis and Crohn's disease using transabdominal ultrasonography. [72] TWIST1+FAP+ fibroblasts in the pathogenesis of intestinal fibrosis in Crohn's disease. [73] The Interplay of Coping Strategies and Quality of Life in Inflammatory Bowel Disease: A Systematic Review. [74] Is cytomegalovirus infection related to inflammatory bowel disease, especially steroid-resistant inflammatory bowel disease? A meta-analysis [75] Is cytomegalovirus infection related to inflammatory bowel disease, especially steroid-resistant inflammatory bowel disease? A meta-analysis [76] Therapeutic Drug Monitoring to Guide Clinical Decision Making in Inflammatory Bowel Disease Patients with Loss of Response to Anti-TNF: A Delphi Technique-Based Consensus. [77] A Matched Case-Control Analysis of Clinical Outcomes for Inflammatory Bowel Disease Patients with Rectal Cancer Treated with Pelvic Radiation Therapy. [78] Rate of, Risk Factors for, and Interventions to Reduce Hospital Readmission in Patients with Inflammatory Bowel Diseases. [79] Commentaries on "workshop report: Developing a pediatric inflammatory bowel diseases network and data platform in canada": International networking in pediatric gastroenterology research: Advancing science and medicine with collaborative efforts [80] Re: Erectile Dysfunction is Highly Prevalent in Men with Newly Diagnosed Inflammatory Bowel Disease [81] Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: multi-center retrospective descriptive study. [82] IMMUNIZATION STATUS OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE. [83] Endoscopic resection for non-polypoid dysplasia in inflammatory bowel disease: a systematic review protocol. [84] [Hodgkin's lymphoma associated with inflammatory bowel disease treated with thiopurines. A case report and review of the literature]. [85] Association of Childhood-Onset Inflammatory Bowel Disease With Risk of Psychiatric Disorders and Suicide Attempt. [86] Diagnostic Challenges in the Early Onset of Inflammatory Bowel Disease: A Case Report. [87] Innovations in Oral Therapies for Inflammatory Bowel Disease. [88] The epidemiology of inflammatory bowel disease: East meets West. [89] Impaired Inactivation of Digestive Proteases in Lower Gut Due to Inhibition of Gut Bacteria by Food Additives Such as Saccharin and Sucralose as Main Cause of Inflammatory Bowel Disease: A Two-Decades-Long Hypothesis Warrants Testing [90] A Systematic Review of Case-Identification Algorithms Based on Italian Healthcare Administrative Databases for Three Relevant Diseases of the Digestive and Genitourinary System: Inflammatory Bowel Diseases, Celiac Disease, and Chronic Kidney Disease. [91] What Should We Expect from Future Therapies for Inflammatory Bowel Disease? [92] The clinical importance of 21-day combined parenteral and enteral nutrition in active inflammatory bowel disease patients [93] Diet in treatment of Inflammatory Bowel Diseases. [94] An In Situ Gelling System for the Local Treatment of Inflammatory Bowel Disease (IBD). The Loading of Maqui () Berry Extract as an Antioxidant and Anti-Inflammatory Agent. [95] Inflammatory Bowel Disease Cohort Studies in Korea: Present and Future [96] Comparative genomics of a subset of Adherent/Invasive Escherichia coli strains isolated from individuals without inflammatory bowel disease. [97] Characteristics and pathogenic role of adherent-invasive Escherichia coli in inflammatory bowel disease: Potential impact on clinical outcomes. [98] The Inflammatory Bowel Disease Drug Azathioprine Induces Autophagy via mTORC1 and the Unfolded Protein Response Sensor PERK. [99] Pathobionts Associated with Inflammatory Bowel Disease. [100] CEACAM6 gene variants in inflammatory bowel disease. [101] W1225 ATG (but Not NOD2 or IRGM) Risk Alleles are Associated With Isolation of Adherent/Invasive E.Coli (AIEC) From Surgically Resected Human Inflammatory Bowel Disease (IBD) Tissues